Product Information
TAMIFLU 6 MG/ML SUSPENSION is a brand product labeled by Genentech, Inc., priced at $2.4329 per ML under NDC 00004082205. Its NADAC has been published 508 times since Nov 28, 2013.
FDA first approved this application on Dec 14, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Oseltamivir Phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/mL
Manufacturer
Genentech, Inc.NDC
00004082205
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA021246FDA Approved
12/14/2000
TE Code
AB
On Market Since
3/21/2011
Pharmacological Classes
Price Statistics
The NADAC for TAMIFLU 6 MG/ML SUSPENSION has been published 508 times since Nov 28, 2013, and over the history we have for it it has risen 42.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4329 per ML |
|---|---|
| All-time high | $2.4394 (Jan 10, 2024) |
| All-time low | $1.7028 (Nov 28, 2013) |
| 52-week high | $2.4329 |
| 52-week low | $2.4308 |
| Median price | $2.4249 |
| Average price | $2.2941 |
| Largest weekly change | +9.0% (Jul 9, 2014) |
| Weeks tracked | 508 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TAMIFLU 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for TAMIFLU 6 MG/ML SUSPENSION, manufactured by Genentech, Inc., is $2.4329 per ML (NDC 00004082205), effective Aug 19, 2026.
How has the price of TAMIFLU 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for TAMIFLU 6 MG/ML SUSPENSION has risen 42.9%. It has been tracked across 508 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TAMIFLU 6 MG/ML SUSPENSION?
Since Nov 28, 2013, the NADAC for TAMIFLU 6 MG/ML SUSPENSION has ranged from a low of $1.7028 (Nov 28, 2013) to a high of $2.4394 (Jan 10, 2024), with a median of $2.4249 per ML.
Are there cheaper alternatives to TAMIFLU 6 MG/ML SUSPENSION?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OSELTAMIVIR 6 MG/ML SUSPENSION, is $0.1511 per ML — about 94% below TAMIFLU 6 MG/ML SUSPENSION.
Who manufactures TAMIFLU 6 MG/ML SUSPENSION?
TAMIFLU 6 MG/ML SUSPENSION (NDC 00004082205) is labeled by Genentech, Inc., and CMS classifies it as a brand product.